FEATURED EDITORIAL
The integration of artificial intelligence (AI) in drug discovery has been a game-changer, significantly improving efficiency and accuracy, and its use is growing exponentially. This article shares market drivers, market restraints, and emerging trends.
- Optimizing Digitalization To Accelerate Your R&D
- Leveraging AI In Drug Discovery To Treat MS & Other Autoimmune Diseases
- Key Considerations For Developing Next-Generation Antibody-Drug Conjugates
- India’s CROs & CDMOs Come Of Age In The Global Marketplace
- 5 Characteristics Of The Automated Microbiology Lab Of The Future
- Risk-Based Strategies For Revalidating Bio/Pharma Equipment & Systems
- Congressional Changes For Orphan Drug Approvals?
FEATURED APPLICATION CONTENT
-
In this study, we used mechanistic modeling to investigate how AAV-resin interactions are affected when MgCl2 is used as an elution additive.
-
A step-by-step high-throughput process development (HTPD) workflow to determine the optimal resin and initial conditions for hydrophobic interaction chromatography (HIC).
-
In this study, we looked at how different antibody binding sites of a protein A ligand are affected by cleaning in place (CIP).
-
Discover a novel approach for manufacturing chemically defined media with precision control of trace impurities that utilizes innovative raw material analysis, data analytics, and a proprietary algorithm.
-
This article discusses how a combination of optimizing your process development, and process intensification can help drive the cost of dose down.
-
Typically, devices containing depth media filters can offer more efficient filtration. Browse depth filtration products and devices for the downstream processing of cell culture solutions, fermentation broths, and lysates.
-
Treatments for glioblastoma multiforme (GBM) are in high demand. Learn more about the new possibilities for increased dosing and diffusion capabilities offered by nanoformed APIs.
-
A novel downstream processing system was developed to mitigate the downstream processing bottleneck in cell line development. Evaluate the performance of this innovative system in a mAb production process.
-
Antibody-drug conjugates (ADCs) represent a significant area of growth in the biopharmaceutical industry. Explore the capabilities of a highly scalable, productive platform to streamline ADC production processes.
-
The first line of defense against cold chain failures is the integrity of freezing containers during storage and shipping. Explore "robust by design" single-use solutions in cold chain management.
-
To evaluate mixing performances across new equipment and consumables to ensure consistency, CFD is invaluable in determining the performance of single-use mixers during process development.
-
Learn about the basic principles that govern tangential flow filtration (TFF) along with the use of TFF capsules and cassettes in laboratory and process development applications.
FEATURED NEWS HEADLINES
- AbCellera Partners With The Governments Of Canada And British Columbia To Advance Drug Development Capabilities And Infrastructure That Will Accelerate Innovative Medicines To Patients
- BioRay Filed IND Application For BRY812, A Novel Antibody Drug Conjugate Targeting LIV-1
- bit.bio Launches New Custom Disease Model Cells Offering, Advancing Disease Research And Drug Discovery
- Cytiva And Pall Life Sciences Complete Integration To Create A Global Innovation And Solutions Leader In Biotechnology
- Capturing Transporter Structure Paves The Way For Drug Development
- Cumberland Pharmaceuticals Announces FDA Clearance Of IND For New Treatment Of Idiopathic Pulmonary Fibrosis
- PharmAbcine Receives IND Approval From The Korean MFDS For Phase I Clinical Trial Of Its Novel TIE2 Agonistic Antibody In nAMD
- Exscientia Highlights ‘The Future Of AI-Enabled Drug Discovery’ At SLAS Europe
- Fujitsu Launches ‘Biodrug Design Accelerator’ Platform To Accelerate Peptide Drug Discovery Research
- OmicsEdge Forms Strategic Partnership With Almaden Genomics To Streamline Drug Discovery
ARCHIVED NEWSLETTER
- 05.26.23 -- Increasing Oral Bioavailability With Solid Form Options
- 05.24.23 -- Addressing Micronization Challenges While Improving Solubility And Sustainability
- 05.23.23 -- Demonstrating Control Over The Manufacturing Process: QbD Studies
- 05.16.23 -- Increase Drug Development Efficiency Using Nanotechnology
- 05.16.23 -- Developing Robust Supply Chain Strategies